Facile synthesis of multi-faceted, biomimetic and cross-protective nanoparticle-based vaccines for drug-resistant Shigella: a flexible platform technology

BACKGROUND: No commercial vaccines are available against drug-resistant Shigella due to serotype-specific/narrow-range of protection. Nanoparticle-based biomimetic vaccines involving stable, conserved, immunogenic proteins fabricated using facile chemistries can help formulate a translatable cross-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Baruah, Namrata, Ahamad, Nadim, Halder, Prolay, Koley, Hemanta, Katti, Dhirendra S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884485/
https://www.ncbi.nlm.nih.gov/pubmed/36710326
http://dx.doi.org/10.1186/s12951-023-01780-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884485/
https://www.ncbi.nlm.nih.gov/pubmed/36710326
http://dx.doi.org/10.1186/s12951-023-01780-y

Ejemplares similares